Population
Patients with primary and secondary pulmonary hypertension, and healthy human volunteers without any family…
Comparison
Measurement of coagulation and fibrinolytic… vs Healthy human volunteers (controls).
Design
Case-control
Authors
Loading...
Elevated PAI-1 and reduced TFPI associate with pulmonary hypertension; hypothesis-generating for prothrombotic mechanisms and antithrombotic trials.
Patients with pulmonary hypertension exhibit a fibrinolytic deficit driven by elevated PAI-1 and decreased TFPI (when right atrial pressure is elevated), suggesting a prothrombotic state that may warrant antithrombotic therapy.
Altman et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: